Holen Sie sich die Stockscreener-App
17.85
0.11%
-0.02
Handel nachbörslich:
17.50
-0.35
-1.96%
Finanzdaten der Dyne Therapeutics Inc-Aktie (DYN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
1.96%
116.13
|
113.89 | 115.79 | 122.37 | 97.11 |
| Operating Income/Loss |
1.96%
-116.13
|
-113.89 | -115.79 | -122.37 | -97.11 |
| Income/Loss From Continuing Operations Before Tax |
3.62%
-111.95
|
-108.04 | -110.86 | -115.36 | -89.54 |
| Income/Loss From Continuing Operations After Tax |
3.62%
-111.95
|
-108.04 | -110.86 | -115.36 | -89.54 |
|
Net Income/Loss
|
3.62%
-111.95
|
-108.04 | -110.86 | -115.36 | -89.54 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
3.95%
-0.73
|
-0.76 | -0.97 | -1.05 | -0.88 |
| Diluted Earnings Per Share |
3.95%
-0.73
|
-0.76 | -0.97 | -1.05 | -0.88 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.80%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):